Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
-
1781por Goto, Yoko, Nakamura, Akira, Ashida, Ryo, Sakanaka, Katsuyuki, Itasaka, Satoshi, Shibuya, Keiko, Matsumoto, Shigemi, Kanai, Masashi, Isoda, Hiroyoshi, Masui, Toshihiko, Kodama, Yuzo, Takaori, Kyoichi, Hiraoka, Masahiro, Mizowaki, Takashi“…BACKGROUND: The purpose was to retrospectively evaluate the effect of intensity-modulated radiotherapy (IMRT) on gastrointestinal (GI) toxicities and outcomes compared to three-dimensional conformal radiotherapy (3DCRT) for locally advanced pancreatic cancer (LAPC). METHODS: We included 107 consecutive patients who underwent CRT for LAPC from September 2001 to March 2015; 80 patients underwent 3DCRT and 27 patients underwent IMRT. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1782
-
1783por Subramani, Ramadevi, Camacho, Fernando A., Levin, Carly Ivy, Flores, Kristina, Clift, Alexa, Galvez, Adriana, Terres, Mauricio, Rivera, Servando, Kolli, Sai Navana, Dodderer, Joshua, Miranda, Megan, Rodriguez, Alejandro, Pedroza, Diego A., Chatterjee, Animesh, Lakshmanaswamy, Rajkumar“…In conclusion, FOXC1 is a potent oncogenic transcription factor, which promotes pancreatic cancer growth and metastasis. Thus, targeting FOXC1 could be a potential therapeutic strategy against pancreatic cancer.…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1784por Guo, Siqi, Burcus, Niculina I., Hornef, James, Jing, Yu, Jiang, Chunqi, Heller, Richard, Beebe, Stephen J.“…A Pancreatic cancer is a notorious malignant neoplasm with an extremely poor prognosis. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1785“…Assessment of these genes in patient biopsies could help further inform risk-stratification and treatment decisions in pancreatic cancer.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1786“…The incidence of pathogenic variants was 13% (37/285) in those with any family history and 23% (13/56) in those with two or more relatives with pancreatic cancer. Those with multiple relatives with pancreatic cancer were significantly more likely to carry a pathogenic variant than those with a personal history of breast cancer under the age of 45 (23.2 vs. 11.9%, p = 0.02). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1787por Papapanagiotou, Angeliki, Sgourakis, George, Karkoulias, Kyriakos, Raptis, Dimitris, Parkin, Edward, Brotzakis, Pantelis, Panchal, Sanjay, Papavassiliou, Athanasios G.“…This prospective pilot study was performed to determine the feasibility of serum osteonectin as a screening tool for pancreatic cancer. METHODS: Blood samples were collected from 15 consecutive patients with newly diagnosed pancreatic cancer and 30 matched healthy controls. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1788por Ntala, Chara, Debernardi, Silvana, Feakins, Roger M., Crnogorac-Jurcevic, Tatjana“…BACKGROUND: Early onset pancreatic cancer (EOPC), i.e. pancreatic ductal adenocarcinoma (PDAC) occurring in patients below 50 years of age, is rare and there is limited information regarding risk factors, molecular basis and outcome. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1789por Chiou, Shin-Heng, Dorsch, Madeleine, Kusch, Eva, Naranjo, Santiago, Kozak, Margaret M., Koong, Albert C., Winslow, Monte M., Grüner, Barbara M.Enlace del recurso
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1790The incidence of venous thromboembolism is not lowin Korean patients with advanced pancreatic cancerpor Yoon, Seug Yun, Lee, Min-Young, Yoon, Jina, Kim, Han Jo, Kim, Kyoung-Ha, Kim, Se Hyung, Lee, Sang-Cheol, Bae, Sang Byung, Kim, Chan-Kyu, Lee, Nam-Su, Lee, Kyu Taek, Park, Sung Kyu, Hong, Dae Sik, Won, Jong-Ho“…BACKGROUND: Pancreatic cancer is among the most common malignancies associated with venous thromboembolism (VTE). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1791por Buwenge, Milly, Macchia, Gabriella, Arcelli, Alessandra, Frakulli, Rezarta, Fuccio, Lorenzo, Guerri, Sara, Grassi, Elisa, Cammelli, Silvia, Cellini, Francesco, Morganti, Alessio G“…SBRT achieves pain relief in most patients with pancreatic cancer with an acceptable gastrointestinal toxicity rate. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1792por Liu, Xinchun, Fu, Yue, Chen, Qiuyang, Wu, Junli, Gao, Wentao, Jiang, Kuirong, Miao, Yi, Wei, JishuEnlace del recurso
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1793por Suker, Mustafa, Nuyttens, Joost J., Groot Koerkamp, Bas, Eskens, Ferry A. L. M., van Eijck, Casper H. J.“…INTRODUCTION: One‐third of the patients with pancreatic cancer present with locally advanced unresectable pancreatic cancer (LAPC). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1794por Li, Wei, Liu, Han, Qian, Weikun, Cheng, Liang, Yan, Bin, Han, Liang, Xu, Qinhong, Ma, Qingyong, Ma, Jiguang“…BACKGROUND: Diabetes mellitus and pancreatic cancer are intimately related. Our previous studies showed that high levels of blood glucose promote epithelial-mesenchymal transition of pancreatic cancer. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1795por McGuigan, Andrew, Kelly, Paul, Turkington, Richard C, Jones, Claire, Coleman, Helen G, McCain, R Stephen“…The identification of novel biomarkers is desirable to move towards a precision medicine era, where pancreatic cancer therapy can be tailored to the individual patient, while unnecessary treatments that have negative consequences on quality of life could be prevented for others. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1796por Santana-Codina, Naiara, Roeth, Anjali A., Zhang, Yi, Yang, Annan, Mashadova, Oksana, Asara, John M., Wang, Xiaoxu, Bronson, Roderick T., Lyssiotis, Costas A., Ying, Haoqiang, Kimmelman, Alec C.Enlace del recurso
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1797por Gu, Dongsheng, Lin, Hai, Zhang, Xiaoli, Fan, Qipeng, Chen, Shaoxiong, Shahda, Safi, Liu, Yunlong, Sun, Jie, Xie, Jingwu“…Pancreatic cancer, mostly pancreatic ductal adenocarcinoma (PDAC), is one of the most lethal cancer types, with an estimated 44,330 death in 2018 in the US alone. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1798por Liu, Yanzhe, Shao, Lijuan, Chen, Kuang, Wang, Zizheng, Wang, Jin, Jing, Wei, Hu, Minggen“…However, the effects of growth differentiation factor (GDF11) in pancreatic cancer remain unclear. PURPOSE: To investigate the expression and significance of GDF11 in pancreatic cancer. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1799por Pothuraju, Ramesh, Rachagani, Satyanarayana, Junker, Wade M., Chaudhary, Sanjib, Saraswathi, Viswanathan, Kaur, Sukhwinder, Batra, Surinder K.“…BACKGROUND: Pancreatic cancer (PC) is among foremost causes of cancer related deaths worldwide due to generic symptoms, lack of effective screening strategies and resistance to chemo- and radiotherapies. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1800